SCHEMBL4898111

SCHEMBL4898111

COC(=O)c1cc(S(=O)(=O)NCCC(c2ccccc2)c2ccccc2)ccc1C

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.82
NPSR1 Q6W5P4 1/20 0.49
KMT2A Q03164 4/20 0.48
CASR P41180 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
KDM4E B2RXH2 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
MEN1 O00255 2/20 0.44
GAA P10253 2/20 0.44
MAPT P10636 1/20 0.44
RECQL P46063 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HTT P42858 1/20 0.44
BDKRB1 P46663 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906975 0.90 LMNA (1.00) LMNANPSR1KMT2AL3MBTL1NPC1
SCHEMBL4900651 0.80 LMNA (0.52) LMNAKMT2ANPC1RAB9AALDH1A1
SCHEMBL4903809 0.77 ALDH1A1 (0.55) LMNAKMT2AMEN1GAAMAPT
SCHEMBL4906713 0.77 TDP1 (0.59) LMNANPSR1KMT2AL3MBTL1NPC1
SCHEMBL19636582 0.76 LMNA (0.76) LMNANPSR1KMT2AL3MBTL1CYP3A4
SCHEMBL4905772 0.76 POLB (0.57) LMNAKMT2AMEN1GAAMAPT
SCHEMBL4909535 0.76 TDP1 (0.57) LMNANPSR1KMT2AL3MBTL1NPC1
SCHEMBL4908501 0.75 HTR6 (0.55) LMNAKMT2AMEN1ALDH1A1
SCHEMBL4902649 0.75 ALDH1A1 (0.54) LMNANPSR1L3MBTL1GAAMAPT
SCHEMBL4905124 0.75 ALDH1A1 (0.55) LMNAKMT2AMEN1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD LMNA 317/4885NPSR1 773/4885KMT2A 3602/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885NPSR1 735/4885KMT2A 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.